1992 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

    Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C. L., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K. & Moriarity, B. S., Jan 8 2020, In : Molecular Therapy. 28, 1

    Research output: Contribution to journalArticle

  • Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study

    Onyeaghala, G., Lane, J., Pankratz, N., Nelson, H. H., Thyagarajan, B., Walcheck, B., Anderson, K. E. & Prizment, A. E., Jun 2019, In : PloS one. 14, 6, e0217868.

    Research output: Contribution to journalArticle

    Open Access
  • iNK-CD64/16A cells: a promising approach for ADCC?

    Walcheck, B. & Wu, J., Dec 2 2019, In : Expert opinion on biological therapy. 19, 12, p. 1229-1232 4 p.

    Research output: Contribution to journalEditorial

    Open Access
  • 7 Scopus citations

    Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells

    Mishra, H. K., Pore, N., Michelotti, E. F. & Walcheck, B., Sep 1 2018, In : Cancer Immunology, Immunotherapy. 67, 9, p. 1407-1416 10 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations